GSLR Drives Lung Adenocarcinoma as a Critical Regulator of Energy Homeostasis Through Creatine Kinase B Activation
Advanced Science · 27.09.2026
DOI: 10.1002/advs.77950 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 27.09.2026. Verfasst von Xinyi Qian und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary and Critical Care Medicine, Regional Medical Center For National Institute of Respiratory Diseases, Sir Run Run Shaw Hospital…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Zhejiang Provincial Leading Geese Plan, Zhejiang Provincial Natural Science Foundation of China.
Abstract (Originalsprache)
Lung cancer remains the leading cause of cancer‐related mortality, with extremely high energy demands during progression. Long non‐coding RNAs (lncRNAs) have emerged as crucial regulators in cancer metabolism; however, their role in reprogramming energy metabolism in lung cancer remains incompletely understood. In this study, we identify a glucose/glutamine sensitive lncRNA, GSLR , as a driver of lung adenocarcinoma (LUAD) progression. GSLR is markedly upregulated in LUAD, and its high expression is associated with poor patient prognosis. Nutrient restriction reduces chromatin accessibility at the GSLR locus via altered histone marks, whereas CTCF activates its transcription. Mechanistically, GSLR directly binds the RNA helicase DHX9 and recruits it to the creatine kinase B (CKB) promoter, arresting R‐loop accumulation and thereby promoting CKB transcription. Elevated CKB expression sustains intracellular ATP homeostasis, thereby stabilizing mitochondrial membrane potential, preventing calcium overload, and reducing reactive oxygen species (ROS) accumulation. Collectively, our findings identify GSLR as a novel regulator of energy homeostasis that promotes lung cancer progression through the GSLR /DHX9/CKB axis. Targeting GSLR may thus represent a promising therapeutic strategy for LUAD.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pulmonary and Critical Care Medicine, Regional Medical Center For National Institute of Respiratory Diseases, Sir Run Run Shaw Hospital and Institute of Translational Medicine, Zhejiang University School o…
- Zhejiang Key Laboratory of Precision Diagnosis and Therapy for Major Gynecological Diseases, Department of Gynecologic Oncology, Women's Hospital and Institute of Translational Medicine, Zhejiang University School of Me…
- Zhejiang Key Laboratory of Frontier Medical Research on Cancer Metabolism, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
ORCID-Profile: Xinyi Qian, Xiaowei Mao, Enguo Chen, Yan Lu, Pengyuan Liu
Förderung
- National Natural Science Foundation of China
- Zhejiang Provincial Leading Geese Plan
- Zhejiang Provincial Natural Science Foundation of China
- China Postdoctoral Science Foundation
Zitieren
APA
Qian, X., Yang, J., Ren, J., Mao, X., Li, J., Sun, T., Dong, L., Chen, E., Lu, Y., & Liu, P. (2026). GSLR Drives Lung Adenocarcinoma as a Critical Regulator of Energy Homeostasis Through Creatine Kinase B Activation. Advanced Science. https://doi.org/10.1002/advs.77950
Vancouver
Qian X, Yang J, Ren J, Mao X, Li J, Sun T, et al. GSLR Drives Lung Adenocarcinoma as a Critical Regulator of Energy Homeostasis Through Creatine Kinase B Activation. Advanced Science. 2026. doi:10.1002/advs.77950
BibTeX
@article{Qian2026,
author = {Qian, Xinyi and Yang, Juze and Ren, Jiayi and Mao, Xiaowei and Li, Jia and Sun, Tengfei and Dong, Liangliang and Chen, Enguo and Lu, Yan and Liu, Pengyuan},
title = {GSLR Drives Lung Adenocarcinoma as a Critical Regulator of Energy Homeostasis Through Creatine Kinase B Activation},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.77950}
}
EUVIMED